Zum Inhalt springen

IDORSIA AG SF-,05

2,27 +0,01 (+0,44%) 28.05.2024, 23:00:04 Uhr
WKN: A2DTEB ISIN: CH0363463438 Wertpapiertyp: Aktie Währung: Euro
  • 1T
  • 1W
  • 1M
  • 3M
  • 6M
  • 1J
  • 3J
  • 5J
  • 10J
  • Max

Weltmärkte

Kursperformance

Zeitraum Kurs %
1 Tag 2,27€ +0,44%
1 Woche 2,22€ +2,45%
1 Monat 1,97€ +14,95%
6 Monate 1,73€ +31,40%
Lfd. Jahr (YTD) 2,32€ -2,04%
1 Jahr 8,01€ -71,66%
3 Jahre 21,90€ -89,63%
5 Jahre 20,99€ -89,19%

Kursdaten

Kurs 2,27€
Eröffnung 2,31€
Geld 2,25€
Brief 2,30€
Tages-Hoch 2,31€
Tages-Tief 2,27€
52 Wochen-Hoch 9,65€
52 Wochen-Tief 1,37€
Allzeit-Hoch 31,65€
Allzeit-Tief 1,37€

Nachrichten

  • GlobeNewswire: Idorsia issues invitation to the 2024 Annual General Meeting of Shareholders - 23.05.2024, 07:00:00 Uhr
  • GlobeNewswire: Idorsia announces changes to Idorsia Executive Committee and Board of Directors - 21.05.2024, 07:00:00 Uhr
  • GlobeNewswire: Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigor - 21.05.2024, 06:50:00 Uhr
  • GlobeNewswire: Idorsia announces financial results for the full year of 2023 – Adapting the company to create sustainable value - 21.05.2024, 06:40:00 Uhr
  • GlobeNewswire: Invitation to Idorsia's Full Year 2023 and Q1 2024 Financial Reporting webcast and conference call - 14.05.2024, 17:45:00 Uhr
  • GlobeNewswire: Bondholders approve amended terms of the 2024 convertible bonds - 06.05.2024, 18:35:00 Uhr
  • GlobeNewswire: Idorsia increases the consent fee in connection with the proposed restructuring of the 2024 convertible bond - 01.05.2024, 18:00:00 Uhr
  • GlobeNewswire: JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension - 26.04.2024, 07:00:00 Uhr
  • GlobeNewswire: Idorsia publishes an invitation to a bondholder meeting - 23.04.2024, 07:00:00 Uhr
  • GlobeNewswire: Idorsia publishes a Financial Status required for an upcoming bondholder meeting - 17.04.2024, 07:00:00 Uhr
Ein Angebot der manager-Gruppe mit Daten von Infront.